Home › Liver Diseases › Louisiana
Liver Diseases clinical trials in Louisiana
3 studies for Liver Diseases are looking for participants at sites in Louisiana.
Cities in Louisiana
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Tandem Clinical Research, Covington
- Tandem Clinical Research, Houma
- Tandem Clinical Research GI, LLC, Marrero
- and 4 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 9, 2026 · NCT07288138A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Lafayette
- 89bio Clinical Study Site, Lake Charles
- 89bio Clinical Study Site, West Monroe
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Covington
- 89bio Clinical Study Site, Houma
- 89bio Clinical Study Site, Lake Charles
- and 2 more
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.